Clinical trial
Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)
NCT05885698 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)
- Lead sponsor
- US Oncology Research
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 30, 2023
- Completion date
- December 31, 2030
- Enrollment
- 7,500 (estimated)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.